Hemmick L M, Bidlack J M
Department of Pharmacology, University of Rochester School of Medicine and Dentistry, NY 14642.
J Neuroimmunol. 1989 Jun;23(1):67-71. doi: 10.1016/0165-5728(89)90074-x.
The opioid peptide beta h-endorphin 1-31 inhibited the plaque-forming cell (PFC) response to sheep red blood cells when rat splenocytes, immunized in vivo, were cultured in vitro with the peptide. The opioid antagonist naloxone failed to reverse the beta h-endorphin 1-31 suppression of the PFC response. Peptide fragments of beta h-endorphin 1-31, other opioid peptides, and alkaloids had no effect on the response. These data indicate that beta h-endorphin 1-31 suppresses antibody production or secretion by a specific, non-opioid receptor on the rat splenocytes.
当在体内免疫的大鼠脾细胞与阿片样肽βh-内啡肽1-31在体外共同培养时,该阿片样肽抑制了对绵羊红细胞的空斑形成细胞(PFC)反应。阿片样拮抗剂纳洛酮未能逆转βh-内啡肽1-31对PFC反应的抑制作用。βh-内啡肽1-31的肽片段、其他阿片样肽和生物碱对该反应无影响。这些数据表明,βh-内啡肽1-31通过大鼠脾细胞上一种特异性的、非阿片样受体抑制抗体的产生或分泌。